![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Raikou M. McGuire A.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.21, Iss.8, 2003-01, pp. : 543-564
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus
Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus
By Landgraf R.
Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Orlistat in the treatment of Type 2 diabetes mellitus
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 5, 2002-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)